Showing results (331-340 of 639) with videos related to
Sort By:
Pageof 64
BMC Musculoskeletal Disorders|August 27, 2016
Effects of a DXA result letter on satisfaction, quality of life, and osteoporosis knowledge: a randomized controlled trialStephanie W Edmonds, Peter Cram, Yiyue Lou, et al.Rheumatology (Oxford, England)|August 21, 2018
Integrated safety studies of the urate reabsorption inhibitor lesinurad in treatment of goutRobert Terkeltaub, Kenneth G Saag, David S Goldfarb, et al.Molecular Pharmaceutics|July 4, 2018
Development of a Janus Kinase Inhibitor Prodrug for the Treatment of Rheumatoid ArthritisXin Wei, Jianbo Wu, Gang Zhao, et al.Arthritis Care & Research|May 25, 2022
Risk of Prostate Cancer in US Veterans With Rheumatoid ArthritisAustin M Wheeler, Punyasha Roul, Yangyuna Yang, et al.Journal of the American Pharmacists Association : Japha|August 28, 2010
Patient-reported communications with pharmacy staff at community pharmacies: the Alabama NSAID Patient Safety Study, 2005-2007Cynthia LaCivita, Ellen Funkhouser, Michael J Miller, et al.AIDS Research and Human Retroviruses|February 16, 2006
Ethnic variations in the prevalence of metabolic bone disease among HIV-positive patients with lipodystrophyJeffrey R Curtis, Barbara Smith, Michael Weaver, et al.Clinical and Experimental Rheumatology|November 13, 2018
Body mass index and persistence of conventional DMARDs and TNF inhibitors in rheumatoid arthritisCaroline B McCulley, Jennifer L Barton, Grant W Cannon, et al.Arthritis Care & Research|August 18, 2019
Performance of Administrative Algorithms to Identify Interstitial Lung Disease in Rheumatoid ArthritisBryant R England, Punyasha Roul, Tina D Mahajan, et al.Frontiers in Immunology|September 1, 2023
Citrullinated and malondialdehyde-acetaldehyde modified fibrinogen activates macrophages and promotes an aggressive synovial fibroblast phenotype in patients with rheumatoid arthritisNozima Aripova, Michael J Duryee, Bryant R England, et al.Annals of the Rheumatic Diseases|December 15, 2015
Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritisAnja Schwenzer, Xia Jiang, Ted R Mikuls, et al.Pageof 64